In the study of several categories of GLP-1 receptor agonists, we discovered that Liraglutide, Semaglutid, and Dulaglutide were connected to the low incidence of respiratory disease
As a result, the regulatory environment for compounded GLP-1 medications continues to shift, and patient access pathways may change over time
So, whether there is a kind of medicine whose effects can cover as many targets as possible is a good question for liver disease therapy
Effects on Chronic Pain Pain is an unpleasant subjective and emotional experience related to actual or potential tissue damage (91)
Peptides 13(1):1316 Sandoval DA, DAlessio DA (2015) Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease
These cases demonstrate the utility of GLP-1 agonists in treating dermatologic conditions that are refractory to other therapies and further highlight the potential of GLP-1 agonists in treating skin disease